Copertina

Pharmacological inhibition of the interleukin‐1 receptor‐associated kinase prevents angiotensin II‐induced cardiac remodelling in mice

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Shreya Jaiswal, Gaurav Sharma, Manoj Kumar Barthwal
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The NADPH oxidase inhibitor Vas2870 prevents myocyte ferroptosis and improves cardiac remodelling and function in doxorubicin‐induced cardiomyopathy
di: Jing Wang, et al.
Pubblicazione: (2026)

Atrial natriuretic peptide counteracts aldosterone secretion by preventing acute angiotensin II‐induced cAMP signalling
di: Sanika Mohagaonkar, et al.
Pubblicazione: (2026)

Dual pharmacological targeting of coactivator‐associated arginine methyltransferase 1 (CARM1) and salt inducible kinase (SIK) drives ketogenesis in both hepatocytes and mice
di: Tábata Bergonci, et al.
Pubblicazione: (2026)

A novel selective stabilizer of the ryanodine receptor 2 prevents stress‐induced ventricular arrhythmias without impairing cardiac function
di: Nagomi Kurebayashi, et al.
Pubblicazione: (2026)

Circular RNA regulatory role in pathological cardiac remodelling
di: Alessia Bibi, et al.
Pubblicazione: (2024)

The sodium–glucose co‐transporter 2 inhibitor, empagliflozin, attenuates pulmonary vascular remodelling by inhibiting the phosphorylation of PDGF receptor‐β
di: Ting‐ting Lyu, et al.
Pubblicazione: (2025)

Neurokinin‐1 receptor activation protects against cardiac fibrosis, inflammation and diastolic dysfunction in type 2 diabetic mice
di: Alexander Widiapradja, et al.
Pubblicazione: (2026)

Bilirubin prevents hyperlipidaemic acute pancreatitis by inhibiting aryl hydrocarbon receptor‐mediated acinar cell pyroptosis
di: Wenjie Liang, et al.
Pubblicazione: (2025)

Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor
di: Zoe Tasma, et al.
Pubblicazione: (2024)

Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis
di: Siyue Chen, et al.
Pubblicazione: (2024)

Effects of vaccines targeting interleukin‐1 receptor, type I on atrial and ventricular function after myocardial infarction
di: Jianwu Huang, et al.
Pubblicazione: (2026)

Efficacy in diet‐induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837
di: Martin E. Cooper, et al.
Pubblicazione: (2024)

Pharmacological targeting of large tumor suppressor kinases (LATS) 1 and 2 augments tissue repair and regeneration
di: Chen Xiao, et al.
Pubblicazione: (2025)

Pharmacological inhibition of hydroxysteroid 11‐beta dehydrogenase type 1 (11‐βHSD1) after myocardial infarction preserves cardiac function in a translational mini‐pig model
di: Sara Al Disi, et al.
Pubblicazione: (2025)

Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs
di: Ian Sayers, et al.
Pubblicazione: (2024)

HIF‐1α and adaptor protein LIM and senescent cell antigen‐like domains protein 1 axis promotes tubulointerstitial fibrosis by interacting with vimentin in angiotensin II‐induced hypertension
di: Wei‐Jie Ni, et al.
Pubblicazione: (2024)

AMP‐activated protein kinase in the amygdala and hippocampus contributes to enhanced fear memory in diabetic mice
di: Aimi Yamagishi, et al.
Pubblicazione: (2024)

Monovalent glycoconjugates of sulforaphane prevent inflammation induced by lipopolysaccharide in human dendritic cells by inhibiting NF‐ĸB signalling pathway
di: Camila Leiva‐Castro, et al.
Pubblicazione: (2025)

Pharmacological inhibition of STING reduces neuroinflammation‐mediated damage post‐traumatic brain injury
di: Amelia L. Fryer, et al.
Pubblicazione: (2024)

Osthole targets doublecortin like kinase 1 (DCLK1/DCAMKL1) in macrophages to inhibit NF‐κB‐mediated inflammation and alleviate atherosclerosis
di: Sirui Shen, et al.
Pubblicazione: (2026)

BRD2‐specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis‐induced C57BL/6 male mice
di: Hyemi Lee, et al.
Pubblicazione: (2024)

The protein disulfide isomerase A3 and osteopontin axis promotes influenza‐induced lung remodelling
di: Amit Kumar, et al.
Pubblicazione: (2024)

Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin‐induced cardiotoxicity
di: Jiajia Wei, et al.
Pubblicazione: (2025)

A comprehensive review of cancer‐induced cardiac wasting
di: Alessia Lena, et al.
Pubblicazione: (2026)

Schwann cell TRPA1 elicits reserpine‐induced fibromyalgia pain in mice
di: Evelyne Silva Brum, et al.
Pubblicazione: (2024)

Silencing the fibronectin gene (FN1 ) improves NaCl‐induced cardiac fibrosis via ferritinophagy‐mediated ferroptosis in a nuclear receptor coactivator 4 (NCOA4)‐dependent manner
di: Yawei Dai, et al.
Pubblicazione: (2025)

Targeting the tyrosine kinase Src in endothelium attenuates inflammation and atherogenesis induced by disturbed flow
di: Huanyu Ding, et al.
Pubblicazione: (2024)

Colchicine effect on biomarkers of cardiac remodelling and atherosclerosis in ST‐elevation myocardial infarction: A randomized controlled trial
di: Hanan Ahmed Hassanain, et al.
Pubblicazione: (2024)

In vitro and in vivo study of butyrylfentanyl and 4‐fluorobutyrylfentanyl in female and male mice: Role of the CRF1 receptor in cardiorespiratory impairment
di: Sabrine Bilel, et al.
Pubblicazione: (2024)

Carvedilol inhibits neuronal hyperexcitability caused by epilepsy‐associated KCNT1 mutations
di: Chang Di, et al.
Pubblicazione: (2024)

Pharmacological treatment with a GABA(A) receptor modulator and a selective serotonin reuptake inhibitor as a mitigation strategy against aircraft noise‐induced cardiovascular and neuronal damage
di: Ivana Kuntić, et al.
Pubblicazione: (2026)

Hand–foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor‐tyrosine kinase inhibitor treatment
di: I‐Hsin Huang, et al.
Pubblicazione: (2026)

Pharmacology of PIEZO1 channels
di: Jacob A. Kinsella, et al.
Pubblicazione: (2024)

Involvement of Piezo 1 in inhibition of shear‐induced platelet activation and arterial thrombosis by ginsenoside Rb1
di: Yilin Wang, et al.
Pubblicazione: (2025)

Airway epithelial overexpressed cathepsin K induces airway remodelling through epithelial–mesenchymal trophic unit activation in asthma
di: Ling Qin, et al.
Pubblicazione: (2024)

Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy
di: Océane Pointeau, et al.
Pubblicazione: (2025)

Correction to “AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis”
Pubblicazione: (2024)

ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents
di: Omar Soler‐Cedeño, et al.
Pubblicazione: (2025)

Toll‐like receptor 4 mediates lipopolysaccharide‐induced emesis
di: Luping Liu, et al.
Pubblicazione: (2026)

Direct neuronal protection by the protease‐activated receptor PAR4 antagonist ML354 after experimental stroke in mice
di: Michael Fleischer, et al.
Pubblicazione: (2024)